https://markets.businessinsider.com/news/stocks/oculis-announces-european-medicines-agency-prime-designation-for-privosegtor-advancing-a-potential-first-in-class-neuroprotective-candidate-for-optic-neuritis-1035979427
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential...
PRIME designation follows recent Breakthrough Therapy designation from the U.S. FDA, underscoring the importance and urgency of addressing optic ...
european medicines agency